[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337698-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337698-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeted-nanoparticle-based-diagnostic-and-treatment-options-for-pancreatic-cancer","Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer","","Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with aggressive metastatic behavior and limited early detection. Dense tumor stroma and a highly complex microenvironment restrict effective drug delivery and worsen therapeutic outcomes. Nanotechnology is presented as a route to improve anticancer delivery and diagnostic precision, including systems for agents such as gemcitabine and paclitaxel. Strategies incorporate targeting ligands, tumor-penetrating peptides, and therapeutic nucleic acids to enhance solubility, circulation, tumor targeting, and controlled release, reducing toxicity and supporting advances in nanomedicine. The review also summarizes targeted mechanisms and notes developments in clinical trial–stage delivery.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeted-nanoparticle-based-diagnostic-and-treatment-options-for-pancreatic-cancer/337698/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeted-nanoparticle-based-diagnostic-and-treatment-options-for-pancreatic-cancer/337698.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes PDAC difficult to diagnose and treat?","Question",{"text":63,"@type":64},"PDAC is highly aggressive and metastatic, with few patients diagnosed at localized, resectable stages. A dense stroma and complex tumor microenvironment hinder effective drug delivery and contribute to resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do targeted nanoparticle systems address delivery barriers in PDAC?",{"text":68,"@type":64},"They can be engineered with targeting ligands and tumor-penetrating peptides to improve intracellular penetration, enhance tumor-site accumulation, and modulate the microenvironment. These designs also support improved solubility, circulation time, and controlled drug release.",{"name":70,"@type":61,"acceptedAnswer":71},"Which nanoparticle-related approaches are highlighted for PDAC diagnosis?",{"text":72,"@type":64},"The review notes that nanoparticles show potential for precise diagnostic methods in PDAC. It emphasizes targeted mechanisms and approaches alongside therapeutic delivery platforms.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337698,1790404310,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":97,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","cancers   \nReview  \nTargeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer  \nXin Gu 1 and Tamara Minko 1,2, *  \nCitation: Gu, X.; Minko, T. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer. Cancers 2024, 16, 1589 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16081589  \nAcademic Editor: Manfred Ogris  \nReceived: 29 February 2024  \nRevised: 17 April 2024  \nAccepted: 19 April 2024  \nPublished: 20 April 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08554, USA  \n2 Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA  \n* [Correspondence: minko@pharmacy.rutgers.edu](Correspondence: minko@pharmacy.rutgers.edu); Tel.: +1-908-307-1550  \nSimple Summary: Pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of pancreatic cancers. It is considered one of the deadliest cancers due to its high metastatic potential and drug resistance. This review discusses various targets and nanoparticle-based delivery systems developed, tested, and approved for the effective diagnosis and targeted treatment of PDAC.  \nAbstract: Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest cancers, presents significant challenges in diagnosis and treatment due to its aggressive, metastatic nature and lack of early detection methods. A key obstacle in PDAC treatment is the highly complex tumor environment characterized by dense stroma surrounding the tumor, which hinders effective drug delivery. Nanotechnology can offer innovative solutions to these challenges, particularly in creating novel drug delivery systems for existing anticancer drugs for PDAC, such as gemcitabine and paclitaxel. By using customization methods such as incorporating conjugated targeting ligands, tumor-penetrating peptides, and therapeutic nucleic acids, these nanoparticle-based systems enhance drug solubility, extend circulation time, improve tumor targeting, and control drug release, thereby minimizing side effects and toxicity in healthy tissues. Moreover, nanoparticles have also shown potential in precise diagnostic methods for PDAC. This literature review will delve into targeted mechanisms, pathways, and approaches in treating pancreatic cancer. Additional emphasis is placed on the study of nanoparticle-based delivery systems, with a brief mention of those in clinical trials. Overall, the overview illustrates the significant advances in nanomedicine, underscoring its role in transcending the constraints of conventional PDAC therapies and diagnostics.  \nKeywords: RNAs; CRISPR; immunotherapy; transferrin receptor (TfR); epidermal growth factor receptor (EGFR); somatostatin receptor 2 (SSTR2); vascular endothelial growth factor receptor (VEGFR); integrin; hyaluronic acid receptors; nanoparticle-based drugs  \n1. Introduction  \nPancreatic ductal adenocarcinoma (PDAC) represents 90% of all pancreatic malignancies and is known as one of the deadliest cancers, with a five-year survival rate of less than 5%, making it a persistent global health challenge [1] . It ranks as the fourth leading cause of cancer death in the United States, leading to over 30,000 deaths every year [2] . PDAC’s highly aggressive and metastatic nature, coupled with the lack of early detection methods, results in fewer than 20% of patients being diagnosed at localized and resectable stages, as 80–85% of advanced PDAC patients are ineligible for surgical intervention due to extensive metastasis [3] . Even those d","cbCaieUdEQKMXMOq","https://ap.wps.com/l/cbCaieUdEQKMXMOq","pdf",5718324,48,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What makes PDAC difficult to diagnose and treat?\",\"answer\":\"PDAC is highly aggressive and metastatic, with few patients diagnosed at localized, resectable stages. A dense stroma and complex tumor microenvironment hinder effective drug delivery and contribute to resistance.\"},{\"question\":\"How do targeted nanoparticle systems address delivery barriers in PDAC?\",\"answer\":\"They can be engineered with targeting ligands and tumor-penetrating peptides to improve intracellular penetration, enhance tumor-site accumulation, and modulate the microenvironment. These designs also support improved solubility, circulation time, and controlled drug release.\"},{\"question\":\"Which nanoparticle-related approaches are highlighted for PDAC diagnosis?\",\"answer\":\"The review notes that nanoparticles show potential for precise diagnostic methods in PDAC. It emphasizes targeted mechanisms and approaches alongside therapeutic delivery platforms.\"}]","Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer | PDF",1790020208,121,[148,152,156,160,164],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d12307e3895af8580b21b0a609ce1f7.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa492709eb3d77f8b95a7fda788e56ef.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e5afd5ea96614cde412a4d868636f42.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3a9e36cb4b5db90da86938bb652cde6.webp",980,1385,{"page_no":97,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/413884cdf377104696a4b8c1e4fe9114.webp",979,1384]